Insigneo Advisory Services LLC Has $490,000 Stake in CME Group Inc. (NASDAQ:CME)

Insigneo Advisory Services LLC trimmed its stake in shares of CME Group Inc. (NASDAQ:CME) by 36.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,482 shares of the financial services provider’s stock after selling 1,421 shares during the period. Insigneo Advisory Services LLC’s holdings in CME Group were worth $490,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. Capital International Investors lifted its holdings in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. lifted its holdings in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after buying an additional 1,309,097 shares during the period. Capital World Investors lifted its holdings in CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after buying an additional 1,172,575 shares during the period. M&G Plc bought a new stake in CME Group in the first quarter valued at approximately $156,631,000. Finally, Assenagon Asset Management S.A. increased its stake in CME Group by 577.9% in the second quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock valued at $126,872,000 after purchasing an additional 550,133 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is owned by corporate insiders.

CME Group Price Performance

CME stock opened at $218.47 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The firm has a market cap of $78.66 billion, a P/E ratio of 24.85, a P/E/G ratio of 8.74 and a beta of 0.55. The company’s 50-day moving average price is $208.97 and its two-hundred day moving average price is $207.48.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.30 EPS. On average, analysts anticipate that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Barclays increased their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. JPMorgan Chase & Co. increased their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Piper Sandler restated an “overweight” rating and set a $225.00 target price on shares of CME Group in a report on Tuesday, August 20th. Finally, Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $212.00 to $177.00 in a report on Tuesday, September 3rd. Four investment analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $210.67.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.